The Effects & Cost-Effectiveness of an Integrated Multidisciplinary

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the effects and cost-effectiveness of a Diagnostic Observation Center for PsychoGeriatric patients (DOC-PG). Our main hypothesis is that DOC-PG has added value compared with usual care regarding Health Related Quality of Life (HRQoL).

Clinical Trial Description

An integrated multidisciplinary approach to diagnosing and managing dementia is generally recommended, though rarely investigated. In recent years, multidisciplinary memory clinics (MCs) for patients with dementia have been established in many places over the world. These services have recently also been criticised for being principally hospital-based, for their apparently limited focus that entails only medical diagnostics and pharmacotherapy and for thus diverting resources from community mental health teams(CMHTs) .On the other hand, CMHTs are mainly concerned with the provision and organisation of integrated care, and unlike MCs, CMHTs generally have limited access to hospital-based diagnostics such as brain-imaging.

In April 2002, an outpatient diagnostic facility, the Diagnostic Observation Centre for PsychoGeriatric patients (DOC-PG) was established in Maastricht, the Netherlands. DOC-PG combines the hospital-based approach of the MC with the care-oriented approach of the regional CMHT and aims to provide the general practitioner (GP) with elaborate diagnostic and therapeutic advice for patients with cognitive disorders.

Comparison: DOC-PG is compared with usual care i.e. the GP took care of the diagnosis, or he or she referred the patient to one of the separate regional services, e.g. the Maastricht Memory Clinic (MMC), geriatric medicine, or the department of mental health for the elderly of the mental health community service (CMHT). ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Cognition Disorders
Delirium, Dementia, Amnestic, Cognitive Disorders
Disease
Memory Disorders

Clinical Trial Details

NCT number	NCT00402311
Study type	Interventional
Source	Maastricht University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	April 2002
Completion date	August 2005

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03894254` - Predictive Factors of Autonomy Loss in Real-life Cohort	N/A
Not yet recruiting	`NCT03507985` - Attention and Memory Disorders Related to Acute Morphine
Terminated	`NCT02521558` - Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease	N/A
Completed	`NCT00355498` - Amyloid Plaque and Tangle Imaging in Aging and Dementia
Completed	`NCT00010920` - Preventing Cognitive Decline With Alternative Therapies	Phase 3
Not yet recruiting	`NCT04079075` - Multiple Interventions to Prevent Cognitive Decline	N/A
Completed	`NCT02185222` - Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint	Phase 3
Completed	`NCT00289471` - Identifying Patients With Dementia in Primary Care	N/A
Terminated	`NCT00548327` - The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype	Phase 2
Completed	`NCT00387062` - Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment	Phase 1
Completed	`NCT00403507` - Exercise Treatment of Mild-Stage Probable Alzheimer's Disease	Phase 2
Completed	`NCT04587583` - WeCareAdvisor: A Web-Based Tool to Improve Quality of Life for Military Veterans With Dementia and Their Caregivers	Phase 1/Phase 2
Completed	`NCT02843529` - Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)	N/A
Active, not recruiting	`NCT03205709` - Cognitive Training and Neuroplasticity in Mild Cognitive Impairment	N/A
Recruiting	`NCT05509075` - Nutraceuticals and Functional Foods
Recruiting	`NCT05065450` - Amygdala Memory Enhancement	N/A
Recruiting	`NCT05929144` - Optimization of MRI Sequences Used in the Study of Neurodegenerative Diseases	N/A
Active, not recruiting	`NCT03661034` - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)	N/A
Completed	`NCT02333942` - Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
Completed	`NCT02236416` - Physical Exercise for Prevention of Dementia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms